Company Filing History:
Years Active: 2020-2025
Title: Innovations of Xiaoyuan Sherry Chi
Introduction
Xiaoyuan Sherry Chi is a notable inventor based in Tenafly, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and antigens related to human cytomegalovirus (CMV). With a total of four patents to his name, Chi's work has implications for medical research and therapeutic applications.
Latest Patents
Chi's latest patents focus on the human cytomegalovirus glycoprotein B (gB). One of his inventions includes polypeptides and CMV antigens that feature at least two introduced amino acid mutations compared to the wild-type HCMV glycoprotein B. These polypeptides are stabilized in a conformation that is alternative to the gB postfusion conformation. Another patent involves mutants of the wild-type CMV glycoprotein B protein, which also includes similar amino acid mutations and compositions that utilize these mutants.
Career Highlights
Xiaoyuan Sherry Chi is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer allows him to collaborate with other experts in the field and contribute to innovative solutions in healthcare.
Collaborations
Chi has worked alongside talented colleagues, including Yuhang Liu and Jennifer Anne Nicki. Their collaborative efforts enhance the research and development processes within their projects.
Conclusion
Xiaoyuan Sherry Chi's contributions to the field of biotechnology through his patents on human cytomegalovirus glycoprotein B highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for future research and therapeutic advancements.